MYC Promotes Tumorigenesis via Activation of CD47 and PD-L1

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2016-051
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression

Molecular Cell
Cell BiologyMolecular Biology
2019English

Regorafenib Promotes Anti-Tumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2019English

The Identification of a CD47-blocking “Hotspot” and Design of a CD47/PD-L1 Dual-Specific Antibody With Limited Hemagglutination

Signal Transduction and Targeted Therapy
Cancer ResearchGenetics
2020English

164 Increased PD-L1 and CD47 Expression in High-Risk Cutaneous Squamous Cell Carcinomas

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Regulation of GVHD and GVL Activity via PD-L1 Interaction With PD-1 and CD80

Frontiers in Immunology
AllergyImmunology
2018English

Correction: Mixed Lineage Kinase 3 Promotes Breast Tumorigenesis via Phosphorylation and Activation of P21-Activated Kinase 1

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

Elimination of Tumor by CD47/PD-L1 Dual-Targeting Fusion Protein That Engages Innate and Adaptive Immune Responses

mAbs
AllergyImmunology
2017English

TEAD4 Promotes Colorectal Tumorigenesis via Transcriptionally Targeting YAP1

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2018English

PD-L1 Regulation by SDH5 via Β-Catenin/Zeb1 Signaling

OncoImmunology
OncologyAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy